The medical relevance of genome variability Gabor T
The medical relevance of genome variability Gabor T. Marth, D. Sc. Department of Biology, Boston College marth@bc. edu Medical Genomics Course – Debrecen, Hungary, May 2006
Lecture overview 1. Phenotypic effects caused by known genetic variants 2. Genetic mapping to find genetic variants that cause diseases – linkage analysis and association studies 3. Genome-wide association mapping resources – the Hap. Map 4. Structural and epigenetic variations in disease
1. Phenotypic effects caused by known genetic variants
Many SNPs do have phenotypic effects some notable genetic diseases: cystic fibrosis cycle-cell anemia Badano and Katsanis, NRG 2002
Genetic variants in Pharmacogenetics Evans and Rellig, Science 1999
Genetic variants in Pharmacogenetics Evans and Rellig, Science 1999
Using genotype information in the drug development pipeline Roses. NRG 2004
Are all genetic variants functional? ~ 10 million known SNPs, on the scale of the genome, can be described well with the “neutral theory” of sequence variations the vast majority of SNPs likely to have no functional effects How do we find the few functional variants in the background of millions of non-functional SNPs?
2. Genetic mapping to find genetic variants that cause diseases – linkage analysis and association studies
Genetic mapping
Allelic association (linkage) • allelic association is the nonrandom assortment between alleles i. e. it measures how well knowledge of the allele state at one site permits prediction at another marker site functional site • significant allelic association between a marker and a functional site permits localization (mapping) even without having the functional site in our collection • allelic association, and the use of genetic markers is the basis for mapping functional alleles
Mendelian diseases have simple inheritance genotype + phenotype inheritance
Linkage analysis compares the transmission of marker genotype and phenotype in families
Complex disease – complex inheritance Badano and Katsanis, NRG 2002
Allele frequency and relative risk Brinkman et al. Nature Reviews Genetics advance online publication; published online 14 March 2006 | doi: 10. 1038/nrg 1828
Association study strategies • region(s) interrogated: single gene, list of candidate genes (“candidate gene study”), or entire genome (“genome scan”) • direct or indirect: causative variant • single-SNP marker or multi. SNP haplotype marker • single-stage or multi-stage marker that is co-inherited with causative variant
Association study strategies for economy, one cannot genotype every SNP in thousands of clinical samples: marker selection is the process where a subset of all available SNPs is chosen 1. hypothesis driven (i. e. based on gene function) 2. LD-driven – based entirely on the reduction of redundancy presented by the linkage disequilibrium (LD) between SNPs; tags represent other SNPs they are correlated with causative variant
Case-control association testing • genotyping cases and controls at various polymorphisms clinical cases • searching for markers with “significant” marker allele frequency differences between cases and controls; these marker signify regions of possible causative alleles AF(controls) clinical controls AF(cases)
Marker selection depends on genome LD Daly et al. NG 2001
3. Genome-wide association mapping resources – the Hap. Map
The Hap. Map resource • goal: to map out human allele and association structure of at the kilobase scale • deliverables: a set of physical and informational reagents
LD structure in four human populations International Hap. Map Consortium, Nature 2005
Genome-wide scans for human diseases SNPs in Complement Factor H (CFH) gene are associated with Age-related Macular Degeneration (AMD) Klein et al, Science 2005
4. Structural and epigenetic variants in disease
Structural variants in disease Feuk et al. Nature Reviews Genetics 7, 85– 97 (February 2006) | doi: 10. 1038/nrg 1767
Structural variations and phenotype Feuk et al. Nature Reviews Genetics 7, 85– 97 (February 2006) | doi: 10. 1038/nrg 1767
Epigenetics and cancer Baylin at al. NRC 2006.
- Slides: 27